Literature DB >> 2464268

Autoantibody responses in the cerebrospinal fluid of guinea pigs with chronic relapsing experimental allergic encephalomyelitis.

A F Walls1, A J Suckling, M G Rumsby.   

Abstract

We report the use of the ELISA technique to measure IgG specific for whole cord, myelin, myelin basic protein and Mycobacterium tuberculosis in the cerebrospinal fluid (CSF) of Strain 13 guinea pigs in different stages of chronic relapsing experimental allergic encephalomyelitis (CR-EAE). Specific antibody levels to all 4 antigen preparations were related to the severity of clinical signs, with the highest levels of IgG in the CSF of guinea pigs in relapse or in stable chronic disease. Total IgG levels in the CSF, though elevated throughout the course of CR-EAE, did not show any association with the category of disease. Control animals inoculated with complete Freund's adjuvant (CFA) alone showed CSF IgG levels specific for M. tuberculosis that were not significantly different from those in animals with chronic EAE, indicating that CFA may itself induce a late-acting increase in blood-brain barrier permeability.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2464268     DOI: 10.1111/j.1600-0404.1988.tb03680.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

Review 1.  Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review.

Authors:  Assaf Menachem; Joab Chapman; Yael Deri; Chaim G Pick; Aviva Katzav
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

2.  Saturable leptin transport across the BBB persists in EAE mice.

Authors:  Hung Hsuchou; Pramod K Mishra; Abba J Kastin; Xiaojun Wu; Yuping Wang; Suidong Ouyang; Weihong Pan
Journal:  J Mol Neurosci       Date:  2013-03-16       Impact factor: 3.444

Review 3.  Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms.

Authors:  H A El-Fawal; S J Waterman; A De Feo; M Y Shamy
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.